Ms. magazine  -- more than a magazine a movement

SIGN UP FOR MS. DIGEST, JOBS, NEWS AND ALERTS

FEMINIST WIRE NEWSBRIEFS

ABOUT
SEE CURRENT ISSUE
SHOP MS. STORE
MS. IN THE CLASSROOM
FEMINIST DAILY WIRE
FEMINIST RESOURCES
PRESS
JOBS AT MS.
READ BACK ISSUES
CONTACT
RSS (XML)
 
feminist wire | daily newsbriefs

June-16-99

Osteoporosis Drug Decreases Risk for Breast Cancer

According to a study published in The Journal of the American Medical Association, a new drug being tested to combat osteoporosis in premenopausal women has been found to simultaneously fight breast disease. An international study conducted in 180 American hospitals and 24 European health centers found that raloxifene reduced a womanís risk of contracting breast cancer by 76%.

The 3-year breast cancer study followed 7,705 women; 2,557 who received one tablet of raloxifene per day, 2,572 who took two raloxifene pills daily, and 2,576 women who took two placebo pills each day. All the women were under 81 years of age.

Results showed that of the women who received either dose of raloxifene (5,129 women), only 13 cases of breast cancer developed. This compares to 26 cases of breast cancer found in the women who took the dummy pills (2,576 women).

Researchers report that raloxifene "prevents estrogen-related breast cancers by occupying the same molecular receptor sites as the estrogen molecule on the surface of cells. [It] blocks estrogen's cancer promoting effects on breast and endometrial tissue . . ." Scientists are comparing this drug with tamoxifen, a similar drug that also obstructs estrogen on breast tissue.

Side effects of raloxifene included blood clots, hot flashes, flu symptoms, cramps, and swelling of the legs. The results of the study found no differences in the effectiveness of the drug in women who received one or two tablets of raloxifene daily. Currently, the study is continuing in order to examine the long-term effects and usefulness of raloxifene in preventing breast cancer.

Media Resources: New York Times - June 16, 1999


© Feminist Majority Foundation, publisher of Ms. magazine

If you liked this story, consider making a tax-deductible donation to support Ms. magazine.

 

 

Send to a Friend
Their
Your
Comments
(optional)


More Feminist News

5/27/2015 California Passes Reproductive FACT Act - The California State Assembly passed the Reproductive Freedom, Accountability, Comprehensive Care and Transparency (FACT) Act yesterday. AB 775, or the FACT Act, passed 48-25 in a vote, and requires that unlicensed facilities in California that provide pregnancy-related services disclose that they are not licensed medical providers. . . .
 
5/26/2015 Ireland Votes Overwhelmingly to Legalize Same-Sex Marriage - Over the weekend, the people of Ireland voted overwhelmingly to pass a national referendum legalizing same-sex marriage. Ireland became the first country in the world to pass marriage equality through popular vote on Friday. . . .
 
5/26/2015 Maryland Governor Will Not Veto LGBT Rights Bills - Maryland Governor Larry Hogan (R) has announced that he will not veto two pieces of legislation protecting LGBT rights passed by the state legislature in March, meaning they will soon become law. The Maryland General Assembly passed SB 743 / HB 862 and SB 416 / HB 838 by wide margins and with bipartisan support on March 24, after which both were sent to the Governor's desk. . . .